(ASND) Ascendis Pharma AS - Performance 18.8% in 12m
Compare ASND with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
9.60%
#28 in Group
Rel. Strength
74.21%
#2058 in Universe
Total Return 12m
18.76%
#41 in Group
Total Return 5y
28.17%
#33 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -3.39%
(?) Percentile in Group
12m Total Return: ASND (18.8%) vs XBI (-5.4%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: ASND vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ASND
Total Return (including Dividends) | ASND | XBI | S&P 500 |
---|---|---|---|
1 Month | 10.59% | 5.55% | -0.45% |
3 Months | 33.88% | -9.75% | -6.29% |
12 Months | 18.76% | -5.39% | 13.04% |
5 Years | 28.17% | -13.20% | 111.82% |
Trend Score (consistency of price movement) | ASND | XBI | S&P 500 |
1 Month | 88.8% | 70% | 47.5% |
3 Months | 60.1% | -88.1% | -87.3% |
12 Months | 42.0% | -44.4% | 54.3% |
5 Years | -22.9% | -53.6% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #87 | 4.77% | 11.1% |
3 Month | #10 | 48.4% | 42.9% |
12 Month | #42 | 25.5% | 5.07% |
5 Years | #32 | 47.7% | -39.5% |
FAQs
Does ASND Ascendis Pharma AS outperforms the market?
Yes,
over the last 12 months ASND made 18.76%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months ASND made 33.88%, while XBI made -9.75%.
Over the last 3 months ASND made 33.88%, while XBI made -9.75%.
Performance Comparison ASND vs Indeces and Sectors
ASND vs. Indices ASND is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 2.23% | 11.0% | 35.3% | 5.72% |
US NASDAQ 100 | QQQ | 1.31% | 8.69% | 34.6% | 3.79% |
US Dow Jones Industrial 30 | DIA | 2.77% | 13.4% | 36.0% | 9.49% |
German DAX 40 | DAX | 2.59% | 10.8% | 17.2% | -6.25% |
Shanghai Shenzhen CSI 300 | CSI 300 | 5.88% | 13.8% | 39.0% | 13.8% |
Hongkong Hang Seng | HSI | 2.63% | 12.1% | 34.7% | 5.83% |
India NIFTY 50 | INDA | 4.75% | 5.71% | 35.4% | 15.9% |
Brasil Bovespa | EWZ | 3.86% | 7.76% | 29.6% | 25.5% |
ASND vs. Sectors ASND is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 2.08% | 11.2% | 29.3% | -4.70% |
Consumer Discretionary | XLY | 2.20% | 11.2% | 34.1% | 4.09% |
Consumer Staples | XLP | 4.29% | 11.4% | 31.2% | 7.82% |
Energy | XLE | 6.49% | 24.6% | 40.4% | 28.1% |
Financial | XLF | 3.34% | 12.6% | 28.3% | -3.91% |
Health Care | XLV | 4.93% | 15.3% | 40.4% | 20.0% |
Industrial | XLI | 1.91% | 10.3% | 34.2% | 8.07% |
Materials | XLB | 4.04% | 13.8% | 43.1% | 23.2% |
Real Estate | XLRE | 2.34% | 11.7% | 35.1% | 0.40% |
Technology | XLK | 0.67% | 8.16% | 38.2% | 8.32% |
Utilities | XLU | 3.51% | 10.5% | 30.8% | -2.03% |
Aerospace & Defense | XAR | 1.20% | 3.61% | 21.4% | -8.72% |
Biotech | XBI | 2.39% | 5.04% | 50.6% | 24.2% |
Homebuilder | XHB | 3.50% | 12.7% | 50.2% | 24.9% |
Retail | XRT | 3.47% | 11.8% | 41.2% | 20.3% |